Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
02/11/1999 | WO1999006579A2 Inhibition of unwanted hormone action in plants |
02/11/1999 | WO1999006578A2 Genetic method for controlling sprouting |
02/11/1999 | WO1999006577A2 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide |
02/11/1999 | WO1999006575A1 Starch debranching enzymes |
02/11/1999 | WO1999006574A1 Cellulose degrading enzymes of aspergillus |
02/11/1999 | WO1999006573A1 New beta-glucanase from a bacillus |
02/11/1999 | WO1999006572A1 Synaptojanin isoform |
02/11/1999 | WO1999006571A1 Cytokinin oxidase |
02/11/1999 | WO1999006569A1 Cytotoxic polypeptide (fragment) derived from ribonuclease |
02/11/1999 | WO1999006566A1 Production of transgenic poinsettia |
02/11/1999 | WO1999006565A2 Antifreeze proteins, dna and expression systems |
02/11/1999 | WO1999006555A1 Novel human mmp-20 protein and use of the same |
02/11/1999 | WO1999006547A2 Products of gene and protein therapy of cystic fibrosis and inducers of a glutathiones-s-transferase |
02/11/1999 | WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto |
02/11/1999 | WO1999006539A1 Zggbp1, novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
02/11/1999 | WO1999006538A1 Thermococcus barosii dna polymerase mutants |
02/11/1999 | WO1999006537A1 Cross-linked polypeptide assay components |
02/11/1999 | WO1999006536A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs |
02/11/1999 | WO1999006072A1 Cyclized prodrugs |
02/11/1999 | WO1999006066A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
02/11/1999 | WO1999005902A1 Transgenic plants tolerant of salinity stress |
02/11/1999 | WO1998050532A3 A process for preparing an anti-oxidant |
02/11/1999 | WO1998049324A3 Carbohydrate-deficient glycoprotein syndrome type i |
02/11/1999 | WO1998049275A3 Archaebacterium intein of the thermococcus fumicolans species |
02/11/1999 | WO1998046771A3 Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same, related proteases, and therapeutic uses thereof |
02/11/1999 | WO1998040474A3 Activated vitamin k-dependent blood factor and method for the production thereof |
02/11/1999 | DE19734218A1 Verfahren zur Ertragssteigerung in Pflanzen Method for increasing yield in plants |
02/11/1999 | DE19733389A1 Mittel zur Expression und zum Nachweis eines ein HPOL-Epitop und ein Polypeptid umfassenden Fusionspolypeptids Means for expression and detection of a HPOL epitope and a polypeptide comprising the fusion polypeptide |
02/11/1999 | CA2633155A1 Stress tolerance and delayed senescence in plants |
02/11/1999 | CA2299623A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs |
02/11/1999 | CA2299620A1 Antifreeze proteins, dna and expression systems |
02/11/1999 | CA2298885A1 Cellulose degrading enzymes of aspergillus |
02/11/1999 | CA2298882A1 Transgenic plants using the tdc gene for crop improvement |
02/11/1999 | CA2298573A1 Synaptojanin isoform |
02/11/1999 | CA2298115A1 Inhibitors of cell-cycle progression and uses related thereto |
02/11/1999 | CA2298062A1 Genetic and protein therapy products for treating cystic fibrosis and inducing a glutathione-s-transferase function |
02/11/1999 | CA2294650A1 Starch debranching enzymes |
02/11/1999 | CA2291944A1 Genetic method for controlling sprouting |
02/11/1999 | CA2239836A1 Novel arginine deiminase |
02/11/1999 | CA2239813A1 Novel nrdd |
02/11/1999 | CA2239221A1 Novel his5 |
02/10/1999 | EP0896063A2 Method for the selection of genetically transformed cells and compounds for use in the method |
02/10/1999 | EP0896062A2 Transformation of alkalophilic bacillus strains |
02/10/1999 | EP0896059A2 Method for the production of pathogen resistant plants |
02/10/1999 | EP0896057A2 D-aminoacylase |
02/10/1999 | EP0896056A1 Novel thermolysin-like protease and use thereof |
02/10/1999 | EP0896055A2 Apoptosis inducing protein and gene encoding the same |
02/10/1999 | EP0895542A1 Derived tyrosine hydroxylase gene expression system |
02/10/1999 | EP0895541A1 Non antibiotic selectable markers for live vaccines |
02/10/1999 | EP0895537A1 Iga1 protease fragment as carrier peptide |
02/10/1999 | EP0895536A2 Isolation of enzymes |
02/10/1999 | EP0752878A4 Products comprising substrates capable of enzymatic cross-linking |
02/10/1999 | CN1207776A Production of ammonium acrylate |
02/10/1999 | CN1207775A Conditionally replicating viral vectors and their use |
02/10/1999 | CN1207774A Method for gene introduction into target cells by retrovirus |
02/10/1999 | CN1207772A Modification process |
02/10/1999 | CN1207770A Enzymes, their preparation and their use in production of ammonium acrylate |
02/10/1999 | CN1207769A Tissue-specific and target RNA-specific ribozymes |
02/10/1999 | CN1207768A Nucleic acid molecule encoding 11-cis retinol dehydrogenase |
02/10/1999 | CN1207645A Process for constructing temp.-tolerant plants |
02/10/1999 | CN1207414A Method for producing glucokinase by gene engrg. technique |
02/09/1999 | US5869720 Transgenic cotton plants producing heterologous peroxidase |
02/09/1999 | US5869719 Introducing a chimeric gene that expresses a sythetase or transferase used in the biosynthetic pathway of biotin, increased enzyme concentration resulting in increased biotin production |
02/09/1999 | US5869701 Method of inactivation of viral and bacterial blood contaminants |
02/09/1999 | US5869641 An isolated modified rna ligand that reacts like an anti-cd4 antibody; treating autoimmune diseases, hiv, antidiabetic and antiarthritic agents |
02/09/1999 | US5869640 Nucleic acids encoding D-type cyclins and hybridization probes |
02/09/1999 | US5869637 Human Kallikrein |
02/09/1999 | US5869634 Method of making an RNA particle for use in cleaving nucleic acid molecules and inserting a nucleic acid molecule into the cleavage site |
02/09/1999 | US5869516 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
02/09/1999 | US5869463 Use of neuro-glial cell lines for transplantation therapy |
02/09/1999 | US5869438 Lipase variants |
02/09/1999 | US5869336 Insect cell viral expression system producing calcium activated neutral protease; treatment of alzheimer's, huntington's, parkinson's, muscular dystrophy and other central nervous system disorders |
02/09/1999 | US5869320 Isolated dna sequence for efficient, selective high level biosynthesis of selected genes |
02/09/1999 | US5869316 Culture medium using 3-deoxy-d-manno-2-octulosonic acid as carbon source to produce aldolase having broad substrate specifity for reverse aldol condensation reaction |
02/09/1999 | US5869315 Modified interleukin-1β converting enzyme with increased stability |
02/09/1999 | US5869314 Tissue plasminogen activators and derivatives thereof as produced by recombinant means |
02/09/1999 | US5869311 Mitochondrial processing peptidase subunit |
02/09/1999 | US5869310 Pure agarlytic enzyme having rapid hydrolsis rates, active at high phs and in most electrophoretic buffers, exhibiting good thermal stability; for recovery of dna from agarose gels |
02/09/1999 | US5869309 Cephalosporin esterase gene from Rhodosporidium toruloides |
02/09/1999 | US5869307 Human GDP-mannose 4,6-dehydratase |
02/09/1999 | US5869304 Technique for specifying the fatty acid at the sn2 position of acylglycerol lipids |
02/09/1999 | US5869302 Analog of haemophilus hin47 with reduced protease activity |
02/09/1999 | US5869301 Method for the production of dicarboxylic acids |
02/09/1999 | US5869299 Using an enzyme system from streptomyces, particularly s. clavuligerus. |
02/09/1999 | US5869298 Stable mutants of D-N-α-carbamoylase and process for preparing D-α-amino acids |
02/09/1999 | US5869291 A polynucleotide coding for guanidine triphosphatases in the ras superfamily; involved in controlling intracellular vesicular transport; diagnosis/treatment of autoimmune disorders, cancer, vesicle, membrane, protein transport |
02/09/1999 | US5869283 Expression cassette operable in a recombinant host |
02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
02/09/1999 | US5869254 In vitro splicing non-viral target nucleic acid with another to correct defect; for gene therapy, viricides |
02/09/1999 | US5869253 Enzymatic ribozyme molecule having a substrate binding site and an active site that cleaves hepatitis c virus rna; diagnosis and viricides |
02/09/1999 | US5869248 Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences |
02/09/1999 | US5869245 Mismatch endonuclease and its use in identifying mutations in targeted polynucleotide strands |
02/09/1999 | US5869043 Csbpbeta protein, cytokine suppressive anti-inflammatory drug (csaid) binding protein |
02/09/1999 | US5869039 X-linked adrenoleukodystrophy gene and corresponding protein |
02/09/1999 | US5869035 Through transfer techniques, cancer cells are engineered to express an epitope which is targeted by natural antibodies causing complement destruction of transformed tumor cells associated with hyperacute xenograft rejection |
02/09/1999 | CA2121180C Norbornane type ester hydrolase |
02/09/1999 | CA1341437E Method of using eukaryotic expression vectors comprising the bk virus enhancer |
02/09/1999 | CA1340384C Methode d'utilisation de vecteurs d'expression eucaryotes comprenant un amplificateur du virus bk |
02/09/1999 | CA1340382C Process for the preparation of 2-arylpropionic acids |
02/09/1999 | CA1340381C Recombinant fusion proteins |